Alfons J.M. van den Eertwegh

Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases.

H. Bontkes, Johan W. Molling, B. von Blomberg, 2008, Immunology letters.

The immunoregulatory role of CD1d-restricted natural killer T cells in disease.

G. Giaccone, H. Pinedo, R. Scheper, 2004, Clinical immunology.

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

I. Lowy, T. D. de Gruijl, K. Jooss, 2013, Cancer Immunology, Immunotherapy.

Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial

T. D. de Gruijl, E. Hooijberg, S. Santegoets, 2019, Cancer Immunology, Immunotherapy.

A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial.

W. Vervenne, J. Coenen, H. P. van den Berg, 2018, European journal of cancer.

In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma

T. D. de Gruijl, A. V. D. van den Eertwegh, B. Sluijter, 2019, Oncoimmunology.

A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial

M. Los, J. M. van Dodewaard-de Jong, H. P. van den Berg, 2017, European Journal of Nuclear Medicine and Molecular Imaging.